3 years 0.73
Extreme 0.73
6.25
5 years 0.73
Extreme 0.73
6.25
10 years 0.73
Extreme 0.73
10
Manager TitleAgeSince
Chief Executive Officer - 01/10/2024
Director of Finance/CFO - 01/10/2024
Chief Operating Officer - 01/10/2024
Director TitleAgeSince
Director/Board Member 63 09/04/2023
Director/Board Member - 01/10/2024
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/24 Issuer sale

Chief Financial Officer

754,058 1.5256%
02/10/24 Issuer sale

Director

74,230 0.1502%
02/10/24 Issuer sale

Director

93,047 0.1882%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 116M
+0.72%+4.45%+20.04%+67.71% 739B
+0.30%+5.57%+15.91%+65.43% 84.85B
-1.71%-2.53%+2.39%+133.44% 64.09B
-0.80%+2.11%-14.16%-0.53% 48.5B
-2.43%+0.84%+4.49%+74.02% 47.09B
-12.18%-25.15%+34.48%+773.65% 45.36B
-0.64%+1.13%+7.36%+24.62% 31.15B
-1.57%+0.48%+44.09%+59.97% 26.25B
+0.72%+4.21%-59.70%-58.14% 25.29B
Average -1.76%-0.99%+6.10%+126.69% 123.51B
Weighted average by Cap. -0.27%+2.48%+15.54%+93.16%
Logo Augmedix, Inc.
Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
Employees
1,430
  1. Stock Market
  2. Stocks
  3. AUGX Stock